An observational study in COPD, sponsored by Centre Hospitalier Universitaire Saint Pierre. Completed at 1 site in Belgium. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2023-01-18.
Sponsored by Centre Hospitalier Universitaire Saint Pierre · Observational
Among 204 studies in Pulmonary Disease, Chronic Obstructive with a site in Belgium — 12 open to participants now, 16 under way, 4 of them phase 3. Pulmonary Disease, Chronic Obstructive · Belgium.
Among the 204 studies in Pulmonary Disease, Chronic Obstructive with a site in Belgium, this one is the 25th largest by enrollment of the 30 observational ones that give a count, is one of 7 that started in 2017, is one of 30 observational ones, and was the 154th registered.
5,520 studies on the registry are indexed under Pulmonary Disease, Chronic Obstructive; 856 are open to participants now.
Browse Pulmonary Disease, Chronic Obstructive studies →12 of the 204 studies in Pulmonary Disease, Chronic Obstructive with a site in Belgium are open now. Recruiting first, the newest first:
KU Leuven · Sites in Belgium
Sanofi · Sites in Belgium, United States, Argentina and 22 more countries
Universitair Ziekenhuis Brussel · Sites in Belgium
GlaxoSmithKline · Sites in Belgium, United States, Argentina and 20 more countries
AstraZeneca · Sites in Belgium, United States, Argentina and 19 more countries
A study can be open while its sites in Belgium have not opened yet or have stopped. Only those recruiting at a site in Belgium →
Of the 555 Pulmonary Disease, Chronic Obstructive studies recruiting now, 305 (55%) set no upper age limit and 82 (15%) stop at 75 or younger; 29 take children under 18; 87 take healthy volunteers.
This study: 18 Years to 90 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
204 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 12 · Phase 2 28 · Phase 3 65 · Phase 4 22
First in 2000; this study’s year is marked. 7 started in 2017.
This study's enrollment of 31 is below the median of 158 across 1,497 observational studies indexed under Pulmonary Disease, Chronic Obstructive.
Median enrollment 110 across the 174 interventional studies, 150 across the 30 observational. Of the 166 that completed or were terminated, 72 (43%) have results posted.
This tab as a report to print or save as PDF → With an account.
125 of 204 have an industry lead sponsor. The 10 most frequent:
Centre Hospitalier Universitaire Saint Pierre is the lead sponsor of 78 studies on the registry; 12 are open to participants now.
Centre Hospitalier Universitaire Saint Pierre has 2 studies filed under Pulmonary Disease, Chronic Obstructive — fewer than ten, so there is no comparison to draw.
4 of the studies in Pulmonary Disease, Chronic Obstructive with a site in Belgium that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05878769Phase 3Hoffmann-La RocheA Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD) | 2027-06-30 |
| NCT05008081Wim JanssensThe CATALINA Study | 2027-03 |
| NCT07045948Universitair Ziekenhuis BrusselBiannual Review of Exhaled Air and Trends in Health Evaluation in COPD | 2027-06-30 |
| NCT07799896Ziekenhuis Oost-LimburgThe Impact of Indoor Environmental Quality on Symptoms in Patients With Chronic Obstructive Pulmonary Disease | 2027-10 |
Among the 204 studies in Pulmonary Disease, Chronic Obstructive with a site in Belgium, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of our study is to assess the impact of pulmonary rehabilitation on objective sleep quality in COPD patients.
COPD patients suffer from bad sleep quality. About 27 -50% are suffering from insomnia, and respiratory related symptoms are also inducing sleep disturbances. Recently, a correlation between altered sleep quality and low activity levels have been shown in this population. In primary insomnia, it is well established that physical activity has a positive impact on sleep quality.
The purpose of our study is to assess the impact of pulmonary rehabilitation on objective sleep quality in COPD patients.
COPD patients physically able to follow a pulmonary rehabilitation program
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
COPD
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
COPD patients following a pulmonary rehabilitation program
Other: pulmonary rehabilitation
a pulmonary rehabilitation program of 30 sessions, (3X1h/ week), will be followed by the COPD patients
sleep efficiency
sleep efficiency assessed by actigraphy
Time frame: 3 +/- 2 months
steps
number of steps walked daily assessed by actigraphy
Time frame: 3 +/- 2 months
Plan to share: No
No publications or documents are linked to this record.
Ran from Nov 2017 to primary completion in Aug 2022, 57 months.
Of 466 non-industry observational studies under Pulmonary Disease, Chronic Obstructive, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 64. This study's 57 months is above that.
Counting every sponsor, half of 586 studies reached it within 26 months; a quarter within 14 and three quarters within 58.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jan 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Pulmonary Disease, Chronic Obstructive →
Centre Hospitalier Universitaire Saint Pierre